Welcome to our dedicated page for Barclays SEC filings (Ticker: BCS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Barclays PLC (BCS) SEC filings page provides access to the company’s regulatory disclosures as a foreign private issuer, including Form 6-K current reports and Form 25 notices for specific securities. Barclays uses these filings to furnish information it provides to the London Stock Exchange and other markets, giving US investors a structured view of its capital, share structure, regulatory interactions and securities actions.
For a commercial and investment bank like Barclays, Form 6-K reports are central. They include quarterly and other results announcements, details of share buy-back programmes and total voting rights, Bank of England stress test outcomes, notices of redemption for capital instruments, and Director/PDMR Shareholding disclosures. These documents show how Barclays manages its common equity Tier 1, Tier 1 capital, total capital and leverage ratios, and how it adjusts its share capital through repurchases and cancellations.
Barclays’ filings also cover structured products and debt securities. Business Wire announcements and related SEC materials describe cash tender offers and consent solicitations for iPath-branded exchange-traded notes, as well as issuer redemptions of ETN series. Selected risk considerations in these documents explain principal risk, market and volatility risk, credit risk of Barclays Bank PLC, concentration risk, liquidity considerations and tax uncertainty for ETN holders.
In addition, Form 25 (25-NSE) notifications document the removal from listing and/or registration on the New York Stock Exchange of particular Barclays debt issues, such as fixed rate senior notes maturing in 2026. These filings relate to specific note classes rather than the Barclays ADRs themselves.
On Stock Titan, these filings are updated as they appear on EDGAR and can be paired with AI-powered summaries that highlight key points in lengthy documents. Users can quickly identify capital ratios, share count changes, insider transactions and the terms of redemptions or tenders without reading every page, while still having direct access to the full original filings for detailed review.
Barclays PLC filed an amendment to its Form 13F to correct reported market values, converting amounts previously shown in thousands to exact dollar values as required. The amendment states positions themselves were not changed; the report lists a Form 13F Information Table Value Total of $272,533,369,358 and is signed on 03-24-2026.
Barclays PLC filed an amended Form 13F (Amendment No. 1) restating reported market values to exact dollar amounts for holdings previously reported in thousands. The amendment updates the Form 13F Information Table Value Total to $287,619,145,141 and confirms 9,054 table entries; the report lists 8 other included managers.
The amendment states positions were unchanged and the correction only affects valuation reporting; the report is signed by Suejean Mott on 03-24-2026.
Barclays plc amended its Form 13F-HR to correct previously reported market values for holdings in the Q2-2024 report from thousands to exact dollar amounts. The amendment states there were no changes to positions; the Form 13F Information Table shows 9,424 entries with a total value of $327,101,700,678. The amendment was signed by Suejean Mott on 03-23-2026 and is strictly related to reporting accuracy.
Barclays PLC filed an amended Form 13F restating previously reported market values to exact dollar amounts; the amendment does not change any positions.
The amendment corrects values that were reported in thousands, lists 9,207 holdings entries, shows a Form 13F table value total of $376,799,329,696, and identifies 7 other included managers.
Barclays PLC amends its Form 13F holdings report to restate market values. This amendment corrects values previously reported in thousands to exact dollar amounts and does not change positions. The Form 13F Information Table shows 9,284 entries with a total market value of $356,858,095,963.
Barclays PLC has filed a Form 6-K reporting share transactions by senior managers. The notice covers disposals of ordinary shares of 25 pence each, carried out by Computershare Investor Services plc as administrator of Barclays' nominee service.
Group Chief Compliance Officer Matthew Fitzwater had 137,780 shares sold at £3.908 per share. Matthew Hammerstein, Chief Executive of the UK Corporate Bank, had 400,000 shares sold at £3.936 per share. Denny Nealon, CEO for Barclays US Consumer Bank and Barclays Bank Delaware, had 73,866 shares sold at £3.918 per share. All transactions took place on 9 March 2026 on the London Stock Exchange.
Barclays PLC has announced a leadership change at its European banking arm. Diony Lebot, an independent Non-Executive Director of Barclays PLC and Barclays Bank Ireland PLC (Barclays Europe), will become Chair of Barclays Europe and Chair of its Nominations Committee from 16 March 2026, following regulatory approval.
This appointment is in addition to her existing Barclays roles. She will succeed Tim Breedon, who will step down as a Non-Executive Director and as Chair of Barclays Europe and Chair of its Nominations Committee on the same date. The Boards thanked Mr Breedon for his stewardship and contribution during his tenure.
Barclays PLC reports extensive share capital activity, centred on its share buy-back programmes and routine insider dealings. The company completed the buy-back announced on 23 October 2025, having repurchased for cancellation 107,319,865 ordinary shares at a volume weighted average price of 465.8970p per share for total consideration of approximately £500 million.
Separately, under the buy-back launched on 10 February 2026, Barclays has purchased 41,431,750 ordinary shares on the London Stock Exchange at a volume weighted average price of 470.5603p per share as of 26 February 2026, all for cancellation. After recent cancellations, its issued share capital consists of 13,797,261,131 ordinary shares with voting rights, with no treasury shares, and 7,127,204 further shares were admitted to trading during January 2026.
The filing also details disposals and acquisitions of shares by senior executives and non-executive directors, including sales administered by Computershare, fee-based share acquisitions for board members at prices around £4.808 per share, and an option exercise resulting in the acquisition of 21,428 shares at £0.84 per share.
Barclays PLC is filing a Form 6-K that is incorporated by reference into its existing Form F-3 shelf registration. The report mainly provides documentation for several senior callable notes, including 4.219% Fixed-to-Floating Rate Senior Callable Notes due 2030, 4.521% Fixed-to-Floating Rate Senior Callable Notes due 2032, 5.207% Fixed-to-Floating Rate Senior Callable Notes due 2037 and Floating Rate Senior Callable Notes due 2030.
The filing lists a February 17, 2026 pricing agreement with Barclays Capital Inc., a February 24, 2026 Twenty-First Supplemental Indenture under the existing senior debt securities indenture, and the related forms of global securities. It also includes U.S. and English legal opinions confirming the validity of these notes.
Barclays PLC filed a quarterly Form 13F holdings report as an institutional investment manager. The filing reports 9,988 separate equity holdings with an aggregate reported value of $416,707,340,414, based on Form 13F reporting rules. Barclays lists 8 other included affiliated managers, such as Barclays Bank PLC and Barclays Capital Inc., indicating that their positions are consolidated in this report. The report is signed by Director Suejean Mott, who certifies that the information provided is true, correct, and complete.